{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:49:38Z","timestamp":1792799378642,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,12,8]],"date-time":"2010-12-08T00:00:00Z","timestamp":1291766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00431-010-1370-9","type":"journal-article","created":{"date-parts":[[2010,12,7]],"date-time":"2010-12-07T06:40:16Z","timestamp":1291704016000},"page":"879-886","source":"Crossref","is-referenced-by-count":13,"title":["Insulin resistance is associated with at least threefold increased risk for prothrombotic state in severely obese youngsters"],"prefix":"10.1007","volume":"170","author":[{"given":"Assimina","family":"Galli-Tsinopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kyrgios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Maggana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni Z.","family":"Giannopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni P.","family":"Kotanidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charilaos","family":"Stylianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Korantzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Varlamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,8]]},"reference":[{"key":"1370_CR1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2337\/diacare.28.suppl_1.S37","volume":"28","author":"American Diabetes Association","year":"2005","unstructured":"American Diabetes Association (2005) Diagnosis and classification of diabetes mellitus. Diab Care 28:37\u201342","journal-title":"Diab Care"},{"key":"1370_CR2","author":"NM Al-Daghri","year":"2010","unstructured":"Al-Daghri NM, Al-Attas OS, Alokail MS et al (2010) Relationship between resistin and aPAI-1 levels with insulin resistance in Saudi children. Pediatr Int. doi: 10.1111\/j.1442-200X.2010.03091.x","journal-title":"Pediatr Int"},{"key":"1370_CR3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.0000080884.27358.49","volume":"108","author":"SS Anand","year":"2003","unstructured":"Anand SS, Yi Q, Gerstein H et al (2003) Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 108:420\u2013425","journal-title":"Circulation"},{"key":"1370_CR4","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1182\/blood.V80.8.1998.1998","volume":"80","author":"M Andrew","year":"1992","unstructured":"Andrew M, Vegh P, Johnston M et al (1992) Maturation of the hemostatic system during childhood. Blood 80:1998\u20132005","journal-title":"Blood"},{"key":"1370_CR5","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1056\/NEJMoa072515","volume":"357","author":"JL Baker","year":"2007","unstructured":"Baker JL, Olsen LW, Sorensen TI (2007) Childhood body mass index and the risk of coronary heart disease in adulthood. N Engl J Med 357:2329\u20132337","journal-title":"N Engl J Med"},{"key":"1370_CR6","doi-asserted-by":"crossref","first-page":"E899","DOI":"10.1152\/ajpendo.00412.2001","volume":"282","author":"P Balagopal","year":"2002","unstructured":"Balagopal P, Sweeten S, Mauras N (2002) Increased synthesis rate of fibrinogen as a basis for its elevated plasma levels in obese female adolescents. Am J Physiol Endocrinol Metab 282:E899\u2013E904","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1370_CR7","first-page":"323","volume":"33","author":"W Bao","year":"1993","unstructured":"Bao W, Srinivasan SR, Berenson GS (1993) Plasma fibrinogen and its correlates in children from a biracial community: the Bogalusa Heart Study. Pediatr Res 33:323\u2013326","journal-title":"Pediatr Res"},{"key":"1370_CR8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/01.CIR.93.1.54","volume":"93","author":"W Bao","year":"1996","unstructured":"Bao W, Srinivasan SR, Berenson GS (1996) Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults: the Bogalusa Heart Study. Circulation 93:54\u201359","journal-title":"Circulation"},{"key":"1370_CR9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/1520-7560(200005\/06)16:3<192::AID-DMRR114>3.0.CO;2-G","volume":"16","author":"JP Bastard","year":"2000","unstructured":"Bastard JP, Pieroni L, Hainque B (2000) Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance. Diab Metab Res Rev 16:192\u2013201","journal-title":"Diab Metab Res Rev"},{"key":"1370_CR10","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1056\/NEJMsa073166","volume":"357","author":"K Bibbins-Domingo","year":"2007","unstructured":"Bibbins-Domingo K, Coxson P, Pletcher MJ et al (2007) Adolescent overweight and future adult coronary heart disease. N Engl J Med 357:2371\u20132379","journal-title":"N Engl J Med"},{"key":"1370_CR11","first-page":"63","volume":"42","author":"S Bilgili","year":"2008","unstructured":"Bilgili S, Celebiler AC, Dogan A, Karaca B (2008) Inverse relationship between adiponectin and plasminogen activator inhibitor-1 in metabolic syndrome patients. Endocr Regul 42:63\u201368","journal-title":"Endocr Regul"},{"key":"1370_CR12","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/sj.ijo.0802381","volume":"27","author":"E Bonora","year":"2003","unstructured":"Bonora E, Kiechl S, Willeit J et al (2003) Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. Int J Obes Relat Metab Disord 27:1283\u20131289","journal-title":"Int J Obes Relat Metab Disord"},{"key":"1370_CR13","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/hq0402.105901","volume":"22","author":"L Calabresi","year":"2002","unstructured":"Calabresi L, Gomaraschi M, Villa B et al (2002) Elevated soluble cellular adhesion molecules in subjects with low HDL-cholesterol. Arterioscler Thromb Vasc Biol 22:656\u2013661","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1370_CR14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/01.ATV.16.3.368","volume":"16","author":"M Cigolini","year":"1996","unstructured":"Cigolini M, Targher G, Bergamo Andreis IA et al (1996) Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. Arterioscler Thromb Vasc Biol 16:368\u2013374","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1370_CR15","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","volume":"320","author":"TJ Cole","year":"2000","unstructured":"Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320:1240\u20131243","journal-title":"BMJ"},{"key":"1370_CR16","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1210\/jc.85.7.2609","volume":"85","author":"DL Crandall","year":"2000","unstructured":"Crandall DL, Busler DE, McHendry-Rinde B et al (2000) Autocrine regulation of human preadipocyte migration by plasminogen activator inhibitor-1. J Clin Endocrinol Metab 85:2609\u20132614","journal-title":"J Clin Endocrinol Metab"},{"key":"1370_CR17","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jama.279.18.1477","volume":"279","author":"J Danesh","year":"1998","unstructured":"Danesh J, Collins R, Appleby P, Peto R (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279:1477\u20131482","journal-title":"JAMA"},{"key":"1370_CR18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/ilar.43.4.207","volume":"43","author":"RB Dell","year":"2002","unstructured":"Dell RB, Holleran S, Ramakrishnan R (2002) Sample size determination. ILAR J 43:207\u2013213, Erratum in: ILAR J 2003;44:239","journal-title":"ILAR J"},{"key":"1370_CR19","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1210\/jc.2004-1741","volume":"90","author":"G Desideri","year":"2005","unstructured":"Desideri G, De Simone M, Iughetti L et al (2005) Early activation of vascular endothelial cells and platelets in obese children. J Clin Endocrinol Metab 90:3145\u20133152","journal-title":"J Clin Endocrinol Metab"},{"key":"1370_CR20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/01.ATV.18.1.20","volume":"18","author":"P Eriksson","year":"1998","unstructured":"Eriksson P, Nilsson L, Karpe F, Hamsten A (1998) Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia. Arterioscler Thromb Vasc Biol 18:20\u201326","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1370_CR21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1055\/s-0037-1613860","volume":"83","author":"P Eriksson","year":"2000","unstructured":"Eriksson P, Van Harmelen V, Hoffstedt J et al (2000) Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals. Thromb Haemost 83:545\u2013548","journal-title":"Thromb Haemost"},{"key":"1370_CR22","doi-asserted-by":"crossref","first-page":"956","DOI":"10.7326\/0003-4819-118-12-199306150-00008","volume":"118","author":"E Ernst","year":"1993","unstructured":"Ernst E, Resch KL (1993) Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 118:956\u2013963","journal-title":"Ann Intern Med"},{"key":"1370_CR23","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/ajcn\/67.6.1136","volume":"67","author":"MA Ferguson","year":"1998","unstructured":"Ferguson MA, Gutin B, Owens S et al (1998) Fat distribution and hemostatic measures in obese children. Am J Clin Nutr 67:1136\u20131140","journal-title":"Am J Clin Nutr"},{"key":"1370_CR24","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2337\/diabetes.51.4.1131","volume":"51","author":"A Festa","year":"2002","unstructured":"Festa A, D'Agostino R Jr, Tracy RP et al (2002) Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51:1131\u20131137","journal-title":"Diabetes"},{"key":"1370_CR25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0021-9150(03)00134-5","volume":"168","author":"ES Ford","year":"2003","unstructured":"Ford ES (2003) The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 168:351\u2013358","journal-title":"Atherosclerosis"},{"key":"1370_CR26","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.ijo.0801427","volume":"24","author":"S Gallistl","year":"2000","unstructured":"Gallistl S, Sudi KM, Borkenstein M et al (2000) Determinants of haemostatic risk factors for coronary heart disease in obese children and adolescents. Int J Obes Relat Metab Disord 24:1459\u20131464","journal-title":"Int J Obes Relat Metab Disord"},{"key":"1370_CR27","first-page":"473","volume":"26","author":"B Garanty-Bogacka","year":"2005","unstructured":"Garanty-Bogacka B, Syrenicz M, Syrenicz A et al (2005) Relation of acute-phase reaction and endothelial activation to insulin resistance and adiposity in obese children and adolescents. Neuroendocrinol Lett 26:473\u2013479","journal-title":"Neuroendocrinol Lett"},{"key":"1370_CR28","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1210\/jc.2008-2534","volume":"94","author":"RB Goldberg","year":"2009","unstructured":"Goldberg RB (2009) Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 94:3171\u20133182","journal-title":"J Clin Endocrinol Metab"},{"key":"1370_CR29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/157339906776818532","volume":"2","author":"JR Greenfield","year":"2006","unstructured":"Greenfield JR, Campbell LV (2006) Relationship between inflammation, insulin resistance and type 2 diabetes: 'Cause or effect'? Curr Diab Rev 2:195\u2013211","journal-title":"Curr Diab Rev"},{"key":"1370_CR30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpeds.2003.09.045","volume":"144","author":"N Gungor","year":"2004","unstructured":"Gungor N, Saad R, Janosky J, Arslanian S (2004) Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr 144:47\u201355","journal-title":"J Pediatr"},{"key":"1370_CR31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF00403280","volume":"34","author":"I Juhan-Vague","year":"1991","unstructured":"Juhan-Vague I, Alessi MC, Vague P (1991) Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 34:457\u2013462","journal-title":"Diabetologia"},{"key":"1370_CR32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/07853899608999095","volume":"28","author":"I Juhan-Vague","year":"1996","unstructured":"Juhan-Vague I, Alessi MC, Vague P (1996) Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus. Ann Med 28:371\u2013380","journal-title":"Ann Med"},{"issue":"Suppl 1","key":"1370_CR33","first-page":"78","volume":"32","author":"I Juhan-Vague","year":"2000","unstructured":"Juhan-Vague I, Alessi MC, Morange PE (2000) Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. Ann Med 32(Suppl 1):78\u201384","journal-title":"Ann Med"},{"key":"1370_CR34","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.258.9.1183","volume":"258","author":"WB Kannel","year":"1987","unstructured":"Kannel WB, Wolf PA, Castelli WP, D'Agostino RB (1987) Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 258:1183\u20131186","journal-title":"JAMA"},{"key":"1370_CR35","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","volume":"89","author":"EE Kershaw","year":"2004","unstructured":"Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548\u20132556","journal-title":"J Clin Endocrinol Metab"},{"key":"1370_CR36","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1160\/TH07-06-0395","volume":"99","author":"ST Kinik","year":"2008","unstructured":"Kinik ST, \u00d6zbek N, Yuce M et al (2008) PAI-1 gene 4G\/5G polymorphism, cytokine levels and their relations with metabolic parameters in obese children. Thromb Haemost 99:352\u2013356","journal-title":"Thromb Haemost"},{"key":"1370_CR37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0268-9499(88)90015-X","volume":"2","author":"C Legnani","year":"1988","unstructured":"Legnani C, Maccaferri M, Tonini P et al (1988) Reduced fibrinolytic response in obese children: association with high baseline activity of the fast acting plasminogen activator inhibitor (PAI-1). Fibrinolysis 2:211\u2013214","journal-title":"Fibrinolysis"},{"key":"1370_CR38","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135\u20131143","journal-title":"Circulation"},{"key":"1370_CR39","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1210\/jc.2004-0616","volume":"89","author":"HS Lim","year":"2004","unstructured":"Lim HS, Lip GY, Blann AD (2004) Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertension. J Clin Endocrinol Metab 89:5377\u20135381","journal-title":"J Clin Endocrinol Metab"},{"key":"1370_CR40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0008-6363(97)00039-4","volume":"34","author":"GYH Lip","year":"1997","unstructured":"Lip GYH, Blann A (1997) von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 34:255\u2013265","journal-title":"Cardiovasc Res"},{"key":"1370_CR41","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.metabol.2008.12.002","volume":"58","author":"S Livadas","year":"2009","unstructured":"Livadas S, Dracopoulou M, Vasileiadi K et al (2009) Elevated coagulation and inflammatory markers in adolescents with a history of premature adrenarche. Metabolism 58:576\u2013581","journal-title":"Metabolism"},{"key":"1370_CR42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/adc.44.235.291","volume":"44","author":"WA Marshall","year":"1969","unstructured":"Marshall WA, Tanner JM (1969) Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291\u2013303","journal-title":"Arch Dis Child"},{"key":"1370_CR43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/adc.45.239.13","volume":"45","author":"WA Marshall","year":"1970","unstructured":"Marshall WA, Tanner JM (1970) Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13\u201323","journal-title":"Arch Dis Child"},{"key":"1370_CR44","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS (1985) Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"1370_CR45","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1210\/jc.2009-1887","volume":"95","author":"N Mauras","year":"2010","unstructured":"Mauras N, DelGiorno C, Kollman C et al (2010) Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. J Clin Endocrinol Metab 95:1060\u20131068","journal-title":"J Clin Endocrinol Metab"},{"key":"1370_CR46","doi-asserted-by":"crossref","first-page":"1307S","DOI":"10.1093\/ajcn\/72.5.1307s","volume":"72","author":"HCJ McGill","year":"2000","unstructured":"McGill HCJ, McMahan CA, Herderick EE et al (2000) Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr 72:1307S\u20131315S","journal-title":"Am J Clin Nutr"},{"key":"1370_CR47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1467-789X.2002.00056.x","volume":"3","author":"I Mertens","year":"2002","unstructured":"Mertens I, Van Gaal LF (2002) Obesity, haemostasis and the fibrinolytic system. Obes Rev 3:85\u2013101","journal-title":"Obes Rev"},{"key":"1370_CR48","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/sj.ijo.0803189","volume":"30","author":"I Mertens","year":"2006","unstructured":"Mertens I, Verrijken A, Michiels JJ et al (2006) Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome. Int J Obes (Lond) 30:1308\u20131314","journal-title":"Int J Obes (Lond)"},{"key":"1370_CR49","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.annepidem.2004.01.002","volume":"14","author":"P Muntner","year":"2004","unstructured":"Muntner P, He J, Chen J et al (2004) Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III). Ann Epidemiol 14:686\u2013695","journal-title":"Ann Epidemiol"},{"key":"1370_CR50","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/MBC.0b013e328304b61a","volume":"19","author":"C Nienaber","year":"2008","unstructured":"Nienaber C, Pieters M, Kruger SH et al (2008) Overfatness, stunting and physical inactivity are determinants of plasminogen activator inhibitor-1activity, fibrinogen and thrombing\u2013antithrombin complex in African adolescents. Blood Coagul Fibrinolysis 19:361\u2013368","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1370_CR51","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.yjmcc.2006.01.022","volume":"40","author":"GD Norata","year":"2006","unstructured":"Norata GD, Grigore L, Raselli S et al (2006) Triglyceride-rich lipoproteins from hypertriglyceridemic subjects induce a pro-inflammatory response in the endothelium: molecular mechanisms and gene expression studies. J Mol Cell Cardiol 40:484\u2013494","journal-title":"J Mol Cell Cardiol"},{"key":"1370_CR52","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","volume":"295","author":"CL Ogden","year":"2006","unstructured":"Ogden CL, Carroll MD, Curtin LR et al (2006) Prevalence of overweight and obesity in the United States, 1999\u20132004. JAMA 295:1549\u20131555","journal-title":"JAMA"},{"key":"1370_CR53","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/oby.2002.98","volume":"10","author":"N Pannacciulli","year":"2002","unstructured":"Pannacciulli N, De Mitrio V, Marino R et al (2002) Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects. Obes Res 10:717\u2013725","journal-title":"Obes Res"},{"key":"1370_CR54","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1172\/JCI115440","volume":"88","author":"MS Sawdey","year":"1991","unstructured":"Sawdey MS, Loskutoff DJ (1991) Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. J Clin Invest 88:1346\u20131353","journal-title":"J Clin Invest"},{"key":"1370_CR55","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.88.22.9959","volume":"88","author":"DJ Schneider","year":"1991","unstructured":"Schneider DJ, Sobel BE (1991) Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states. Proc Natl Acad Sci USA 88:9959\u20139963","journal-title":"Proc Natl Acad Sci USA"},{"key":"1370_CR56","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nm0796-800","volume":"2","author":"I Shimomura","year":"1996","unstructured":"Shimomura I, Funahashi T, Takahashi M et al (1996) Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 2:800\u2013803","journal-title":"Nat Med"},{"key":"1370_CR57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MPH.0b013e3180308749","volume":"29","author":"D Sosothikul","year":"2007","unstructured":"Sosothikul D, Seksarn P, Lusher JM (2007) Pediatric reference values for molecular markers in hemostasis. J Pediatr Hematol Oncol 29:19\u201322","journal-title":"J Pediatr Hematol Oncol"},{"key":"1370_CR58","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1053\/meta.2000.6736","volume":"49","author":"KM Sudi","year":"2000","unstructured":"Sudi KM, Gallistl S, Weinhandl G et al (2000) Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents. Metabolism 49:890\u2013895","journal-title":"Metabolism"},{"key":"1370_CR59","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.coph.2005.01.007","volume":"5","author":"BD Taeye","year":"2005","unstructured":"Taeye BD, Smith LH, Vaughan DE (2005) Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease. Curr Opin Pharmacol 5:149\u2013154","journal-title":"Curr Opin Pharmacol"},{"key":"1370_CR60","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1161\/01.CIR.98.21.2241","volume":"98","author":"AM Thogersen","year":"1998","unstructured":"Thogersen AM, Jansson JH, Boman K et al (1998) High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 98:2241\u20132247","journal-title":"Circulation"},{"key":"1370_CR61","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0026-0495(89)90241-2","volume":"38","author":"P Vague","year":"1989","unstructured":"Vague P, Juhan-Vague I, Chabert V et al (1989) Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women. Metabolism 38:913\u2013915","journal-title":"Metabolism"},{"key":"1370_CR62","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1530\/EJE-06-0662","volume":"156","author":"M Valle Jim\u00e9nez","year":"2007","unstructured":"Valle Jim\u00e9nez M, Estepa RM, Camacho RM et al (2007) Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children. Eur J Endocrinol 156:497\u2013502","journal-title":"Eur J Endocrinol"},{"key":"1370_CR63","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0026-0495(00)80047-5","volume":"49","author":"M Valle","year":"2000","unstructured":"Valle M, Gascon F, Martos R et al (2000) Infantile obesity: a situation of atherothrombotic risk? Metabolism 49:672\u2013675","journal-title":"Metabolism"},{"key":"1370_CR64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1262-3636(07)70167-2","volume":"31","author":"M Valle","year":"2005","unstructured":"Valle M, Martos R, Gascon F et al (2005) Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diab Metab 31:55\u201362","journal-title":"Diab Metab"},{"key":"1370_CR65","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-5448.2007.00271.x","volume":"8","author":"P Zimmet","year":"2007","unstructured":"Zimmet P, Alberti GKMM, Kaufman F et al (2007) The metabolic syndrome in children and adolescents\u2014an IDF consensus report. Pediatr Diab 8:299\u2013306","journal-title":"Pediatr Diab"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-010-1370-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-010-1370-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-010-1370-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T10:54:06Z","timestamp":1592132046000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-010-1370-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,8]]},"references-count":65,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1370"],"URL":"https:\/\/doi.org\/10.1007\/s00431-010-1370-9","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,8]]}}}